He's a paid troll that's been infecting the ONVO board for months and the best bet is that his/her/it's
employer is short AVXL. The real problem is the CEO's of both companies. Through lack of credible information, both have made their shareholders vulnerable to short attacks. Shorts love small biotech
companies simply because their founders are usually great scientists but don't have the Wall Street support or savvy to defend against short hedge funds. They tend to act like high school science projects instead of public companies. Jesse Livermore once said that "if you are a public company, your most important product is your stock price. These CEO's should be mandated to read Livermore before accepting public money.
The only solution is for Missling to release the results or, at the very least, give an update with the links to th Australian news. He's asleep at the switch as far as Wall Street is concerned
Or networks picked up on the Australin news or broadcasts. You would think that the P.R. Firm for Anavex would have at least fed it out to the news services. Even it was only two people, the results were better than anything seen in other trials. A lot of people would be hopeful after seeing the videos
Until Missling unveils the 12/26 data, AVXL remains a target for shorts. Email the IR department. You'll get the same meaningless reply but if more outspoken investors that are mad bombard them, they may actually start to push the third party evaluator to get on the stick.
Missling gets off of his #$%$ and releases the data, we've seen nothing. The raw data has been in existence for 15 weeks and for the third party evaluator not to have a compilation is grounds for breach of contract. Missing is like many small biotech CEO' s in that they are bogged down in their science projects. If Missling can't control his subcontractors, he doesn't belong as the head of a public company. Either release the data or its time for the SEC to look into Missling directly
If they don't release some kind of update, Missling will appear to either be a dolt or to be sandbagging the results. Either way, if he's holding back on what could be a "material event", he's inviting the schmuck lawyers to sue him to eternity.
On a day when most of Wall St. is empty(Passover), this kind of volume is coming from offshore and a logical guess would be that some kind of price for FL has finally been agreed to. Next week will tell the story
The market obviously disagrees with you. The only thing that is going on is simply that Missling can't control his subcontractors. Fifteen weeks to do a compilation?? The fact that it's taking this long is leading people to believe that the results are less than stellar and the BS about a partnership is exactly what it is...BS
They completed the 12 week phase in early January and it's now been 15 weeks with no update. The 12 week data is definitely a "material event" and maybe a call from one of the schmuck lawyers regarding Sarbanes Oxley might tickle the "good doctor" into making an attempt at keeping shareholders informed.
idiotic moron! 20F was filed on Apr 6 and financials on Apr 12. Your catlike reflexes are more like #$%$ convulsions
Motley fool has an easy target with ONVO. Murphy has no cheerleaders on Wall St since he reuses to give any credible guidance on how the company is doing. The shorts are hailing Murphy as their best friend and the only time that they have to be concerned about covering is once a year. Great science and a company that should be taken private or replace the CEO
Unfortunately, the shorts don't have to work too hard since Murphy is the shorts best friend. His secrecy speaks volumes and his attitude or running a high school science project is the biggest problem for shareholders. Promising science....lousy management
You're obviously far more knowledgeable about the science side than most people on this board but if my facts are right, the 12 week raw data should have been available in January. The compilation of the data should not have taken what is now another 14 weeks. Missling has contracted out the study so if he were any kind of a CEO, he would have demanded a completion date from his sub contractor. Net result is that the science may be exemplary but management, as in many small biotechs, is weak and not supportive of shareholders. Any insight as to why CTAD is dragging their feet would be appreciated.
Do you believe:
A hack political science major who's paid to bash or do you believe the FDA, a scientific advisory board with undeniable credibility, and a company who was mandated to announce the ODD because it constitutes a material event?? Make your own decisions and act accordingly.
This is for 3-71 so the 2-73 results, if they're good, should guarantee a partnership with one of the big pharma companies
What Murphy has succesfully done is alienate the analyst community so that institutional buyers won't touch ONVO because they would be investing in the dark. Murphy's practice of "keeping everything a secret" has done significant and lasting damage to the share price. The street operates on guidance and when a CEO refuses to give any, buyer interest dries up and the shorts get free reign. Rather than having invested in the concept and science I should have been far more sceptical of his leadership abilities and credibility on Wall Street. The result has been disastrous and the board doesn't really control anything due to the shares that Murphy owns. This company is like a "mom and pop" science experiment and if they ever decide to act like a real public company, the share price just might come out of the cellar.
That's the identical response that they have sent to everyone. Fact: the raw data has been with the aggregator since late January and Missling evidently doesn't have the clout to give Cogstate a deadline. We're at the mercy of the company as to what the data actually says. Seems like a bit of BS on the part of Missling and IR.
If, as apple and the bashers say, the execs are treated in a favored status, the 135 million for 22% would put the FL price at about 608 million. If the price represented a 10% discount for an insider the final price for FL would be $668 million USD